119 related articles for article (PubMed ID: 2463178)
21. Increased behavioural response to intrathecal substance P after intracerebroventricular 5,7-dihydroxytryptamine but not after p-chlorophenylalanine administration.
Eide PK; Hole K; Broch OJ
Acta Physiol Scand; 1988 Mar; 132(3):419-23. PubMed ID: 2465667
[TBL] [Abstract][Full Text] [Related]
22. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
Green AR; Youdim MB
Br J Pharmacol; 1975 Nov; 55(3):415-22. PubMed ID: 1203627
[TBL] [Abstract][Full Text] [Related]
23. Function of serotonin in physiologic secretion of growth hormone and prolactin: action of 5,7-dihydroxytryptamine, fenfluramine and p-chlorophenylalanine.
Willoughby JO; Menadue M; Jervois P
Brain Res; 1982 Oct; 249(2):291-9. PubMed ID: 6291713
[TBL] [Abstract][Full Text] [Related]
24. A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments.
Hensler JG; Kovachich GB; Frazer A
Neuropsychopharmacology; 1991 Feb; 4(2):131-44. PubMed ID: 2025379
[TBL] [Abstract][Full Text] [Related]
25. Regional inhibition of monoamine oxidase activity by administration of clorgyline in rat brain.
Kunimoto N; Hazama H; Kamase H; Mizukawa R
Folia Psychiatr Neurol Jpn; 1983; 37(1):101-5. PubMed ID: 6884911
[TBL] [Abstract][Full Text] [Related]
26. Selective destruction of midbrain raphe nuclei by 5,7-DHT: is brain 5-HT involved in alcohol drinking in Sprague-Dawley rats?
Adell A; Myers RD
Brain Res; 1995 Sep; 693(1-2):70-9. PubMed ID: 8653423
[TBL] [Abstract][Full Text] [Related]
27. Effect of a selective 5-HT uptake inhibitor--Lu 10-171--on rat brain 5-HT turnover.
Hyttel J
Acta Pharmacol Toxicol (Copenh); 1977 Mar; 40(3):439-46. PubMed ID: 139078
[TBL] [Abstract][Full Text] [Related]
28. Down-regulation of beta-adrenoceptors in rat cortex by repeated administration of desipramine, electroconvulsive shock and clenbuterol requires 5-HT neurones but not 5-HT.
Nimgaonkar VL; Goodwin GM; Davies CL; Green AR
Neuropharmacology; 1985 Apr; 24(4):279-83. PubMed ID: 2987723
[TBL] [Abstract][Full Text] [Related]
29. Self-stimulation responses are altered following long-term but not short-term treatment with clorgyline.
Aulakh CS; Cohen RM; Pradhan SN; Murphy DL
Brain Res; 1983 Jul; 270(2):383-6. PubMed ID: 6883106
[TBL] [Abstract][Full Text] [Related]
30. Regeneration of serotonergic fibers in the rat hypothalamus following unilateral 5,7-dihydroxytryptamine injection.
Frankfurt M; Azmitia E
Brain Res; 1984 Apr; 298(2):273-82. PubMed ID: 6609746
[TBL] [Abstract][Full Text] [Related]
31. Selective inhibition of MAO-A but not MAO-B activity increases rat pineal melatonin.
Oxenkrug GF; McCauley R; McIntyre IM; Filipowicz C
J Neural Transm; 1985; 61(3-4):265-70. PubMed ID: 2580945
[TBL] [Abstract][Full Text] [Related]
32. Effects of serotonergic denervation on the density and plasticity of brain muscarinic receptors in the rat.
Alonso R; Soubrie P
Synapse; 1991 May; 8(1):30-7. PubMed ID: 1714634
[TBL] [Abstract][Full Text] [Related]
33. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Ribas C; Miralles A; García-Sevilla JA
Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
[TBL] [Abstract][Full Text] [Related]
34. Effects of clorgyline and deprenil on corticosterone levels in rats.
Ventura MA
Eur J Pharmacol; 1982 Jul; 81(3):349-55. PubMed ID: 6214412
[TBL] [Abstract][Full Text] [Related]
35. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of tryptamine receptors following chronic administration of clorgyline.
Martin LL; Neale RF; Wood PL
Brain Res; 1987 Sep; 419(1-2):239-43. PubMed ID: 3676728
[TBL] [Abstract][Full Text] [Related]
37. Effect of co-administration of varenicline and antidepressants on extracellular monoamine concentrations in rat prefrontal cortex.
Rollema H; Wilson GG; Lee TC; Folgering JH; Flik G
Neurochem Int; 2011 Jan; 58(1):78-84. PubMed ID: 21056607
[TBL] [Abstract][Full Text] [Related]
38. Interaction of beta-adrenoceptor agonists with the serotonergic system in rat brain. A behavioral study using the L-5-HTP syndrome.
Ortmann R; Martin S; Radeke E; Delini-Stula A
Naunyn Schmiedebergs Arch Pharmacol; 1981 Jun; 316(3):225-30. PubMed ID: 6114439
[TBL] [Abstract][Full Text] [Related]
39. Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline.
Aulakh CS; Hill JL; Wozniak KM; Murphy DL
Psychopharmacology (Berl); 1988; 95(3):313-7. PubMed ID: 3137616
[TBL] [Abstract][Full Text] [Related]
40. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function.
Pranzatelli MR; Snodgrass SR
Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
